Back to article: To promote or inhibit glioma progression, that is the question for IL-33

FIGURE 2: IL-33 nuclear function creates a switch-hitting cytokine in glioma progression. Schematics show the interplay between tumor associated macrophage (TAM) and glioma cells expressing full-length IL-33 (upper panel) or nuclear localization deficient IL-33 (ΔNLS-IL33; lower panel). Right panels show immunohistochemical images of brain sections from SCID mice bearing IL-33 (top) or ΔNLS-IL33 (bottom) expressing human glioma tumor cells co-stained for Iba-1 (green) to detect microglia/macrophage and anti-human nucleolin (red) to detect tumor cells.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.